Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc.filedCriticalPfizer Inc.
Priority to YU104192ApriorityCriticalpatent/YU48292B/sh
Publication of YU104192ApublicationCriticalpatent/YU104192A/sh
Publication of YU48292BpublicationCriticalpatent/YU48292B/sh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
2-(4-HIDROKSIPIPERIODINO)-1-ALKANOL DERIVATI, niz od 2-(4-hidroksipiperidino)-l-alkanol derivati su korisni kao lekovi za lečenje traumatskih povreda mozga i kičmene moždine i degenerativnih obolenja neurone uključujući staračku izlapelost, kod sisara, naročito kod ljudi.
Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system